Diabetes and COVID-19

COVID chapter

Diabetes is a strong risk factor for adverse COVID-19 outcomes. In 2021 IDF Diabetes Atlas reported that individuals with diabetes experience a substantially greater likelihood of hospitalsation and death as a result of COVID-19 infections compared to those without.

A systematic review was performed in 2022 to assess the likelihood of adverse COVID-19 outcomes in relation to glycaemic control, blood glucose levels on admission to hospital, and diabetes subtype.

35-40% increase in the odds of COVID-19 hospitalisation and severe illness for adults with diabetes and haemoglobin A1c levels over or equal to 7%